overactive bladder

As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma
As Urovant gears up for vibegron FDA decision, the biotech gets snapped up by Sumitovant Biopharma
Fierce Biotech
Urovant
Roivant
FDA
vibegron
overactive bladder
Flag link:
UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
UroGen presses ahead with RTGel after Botox pairing stumbles in overactive bladder trial
Fierce Pharma
Urogen
AbbVie
Jelmyto
overactive bladder
Flag link:
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
AbbVie
Urogen
overactive bladder
Allergan
Botox
Flag link:
FDA sets Dec. PDUFA date for Urovant rival to Astellas drug
FDA sets Dec. PDUFA date for Urovant rival to Astellas drug
Fierce Biotech
Urovant Sciences
overactive bladder
vibegron
FDA
Flag link:
FDA Approves Smart Programmer for Medtronic Neuromodulation System
FDA Approves Smart Programmer for Medtronic Neuromodulation System
Medical Devices and Diagnostics Industry
devices
Medtronic
FDA
InterStim
sacral neuromodulation
overactive bladder
Flag link:
Urovant's overactive bladder drug scores in mid-stage trial
Urovant's overactive bladder drug scores in mid-stage trial
Endpoints
Urovant Sciences
overactive bladder
clinical trials
vibegron
Flag link:
Urovant seeks $150M IPO just a year after launch
Urovant seeks $150M IPO just a year after launch
Fierce Biotech
Urovant Sciences
IPOs
Merck
Roivant
overactive bladder
Flag link:
Teva Pharma Detrol Launches Sales of Generic Detrol
Teva Pharma Detrol Launches Sales of Generic Detrol
Daily Finance
generics
Teva
Detrol LA
overactive bladder
Flag link:
FDA OKs over-the-counter version of Merck overactive bladder drug
FDA OKs over-the-counter version of Merck overactive bladder drug
Reuters
FDA
Merck
overactive bladder
Oxytrol
Flag link:
Allergan's Botox Label Expanded
Allergan's Botox Label Expanded
Yahoo/Zacks
Allergan
Botox
overactive bladder
Flag link:
Mylan Inc arm gets US OK for Tolterodine tartrate tablets
Mylan Inc arm gets US OK for Tolterodine tartrate tablets
Healthcare Global
Mylan
generics
Detrol
overactive bladder
Flag link:
Merck May Not Have Shown Women Can Safely Choose Drug
Merck May Not Have Shown Women Can Safely Choose Drug
Bloomberg
Merck
Oxytrol
overactive bladder
Flag link:
Astellas launches bladder drug, aiming for a $1.9B franchise
Astellas launches bladder drug, aiming for a $1.9B franchise
Fierce Pharma
Astellas
Myrbetriq
overactive bladder
Flag link:
Allergan’s Botox Shot Helps Overactive Bladder in Women
Allergan’s Botox Shot Helps Overactive Bladder in Women
Bloomberg
Botox
Allergan
overactive bladder
Flag link:
Pfizer
Pfizer
Yahoo/Investor's Business Daily
Pfizer
Mylan
Detrol
overactive bladder
Flag link:
Mylan will launch generic Detrol LA in 2014
Mylan will launch generic Detrol LA in 2014
Yahoo/AP
Detrol LA
generics
Mylan
Pfizer
overactive bladder
Flag link:
Astellas Bladder Treatment Wins U.S. Approval For Sale
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Astellas
FDA
overactive bladder
mirabegron
Flag link:
Watson Pharma says federal appeals court agrees 4 Sanctura XR patents are not valid
Watson Pharma says federal appeals court agrees 4 Sanctura XR patents are not valid
Yahoo/AP
Watson
Sanctura XR
patents
overactive bladder
Flag link:
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Pharmabiz
Watson Pharmaceuticals
Antares Pharma
Gelnique
overactive bladder
Flag link:
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
FDA
overactive bladder
Astellas
mirabegron
Flag link:

Pages